Bora Pharmaceuticals Co., LTD. (TWSE:6472) agreed to acquire remaining 34.3% stake in Bora Biologics Co., Ltd. for TWD 1.4 billion on April 12, 2024. As per the transaction, Bora Pharmaceuticals Co., LTD. will issue 1 share for 14.205 shares of Bora Biologics Co., Ltd. Bora Pharmaceuticals Co., LTD. expected to issue 1.7 million shares for the transaction. The transaction is approved by board of directors of Bora Biologics Co., Ltd. The transaction is expected to close on July 26, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
713 TWD | -0.28% | -4.42% | +11.58% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.58% | 2.21B | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- 6472 Stock
- News Bora Pharmaceuticals Co., LTD.
- Bora Pharmaceuticals Co., LTD. agreed to acquire remaining 34.3% stake in Bora Biologics Co., Ltd.